Rocket


Overview
Financials
News + Filings

 
 

Chromocell Therapeutics Corp Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20
Revenues0.00.2
            Revenue growth-100.0% 
Cost of goods sold0.00.0
Gross profit0.00.2
            Gross margin 100.0%
Selling, general and administrative0.61.4
Research and development0.20.1
General and administrative0.51.3
EBIT-0.8-2.0
            EBIT margin -1024.8%
Pre-tax income-0.6-0.7
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-0.6-0.7
            Net margin -330.4%
 
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy